Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PGD | P52209 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28165325 | 1.00 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL360335 | 1.00 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL27496778 | 0.98 | PDE4A (0.54) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL3350436 | 0.93 | PDE4A (0.46) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL27637592 | 0.83 | PDE4A (0.52) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL9387950 | 0.81 | — | — | |
| Mannitol SCHEMBL21272731 | 0.79 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL710524 | 0.79 | USP2 (0.59) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL536485 | 0.79 | PDE4A (0.47) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL3687107 | 0.79 | PDE4A (0.47) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119570647-A | Genetically engineered bacterium for producing 2' -fucosyllactose based on mannitol, construction method and application thereof | 山东大学 | 2025-03-07 | — | — | CN | claimed |
| CN-116622534-A | Engineering strain for high yield of 2' -fucosyllactose, construction method and application thereof | 山东大学 | 2023-08-22 | — | — | CN | claimed |
| CN-1235597-C | Wound nursing medicinal composition | LING PEIXUE (CN) | 2006-01-11 | — | — | CN | claimed |
| CN-1543983-A | Wound nursing medicinal composition | 凌沛学 | 2004-11-10 | — | — | CN | claimed |
| EP-0841931-A1 | PHARMACEUTICAL COMPOSITION | THE VICTORIA UNIVERSITY OF MANCHESTER (GB) | 1998-05-20 | — | — | EP | claimed |
| WO-1997005883-A1 | PHARMACEUTICAL COMPOSITION | THE VICTORIA UNIVERSITY OF MANCHESTER (GB) | 1997-02-20 | — | — | WO | claimed |
| CN-119570647-A | Genetically engineered bacterium for producing 2' -fucosyllactose based on mannitol, construction method and application thereof | 山东大学 | 2025-03-07 | — | — | CN | disclosed |
| CN-118792373-A | Application of salt-tolerant bacillus in fermentation preparation of soybean meal polypeptide | 内蒙古大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-113754739-B | Preparation method and application of coronavirus S protein RBD glycoprotein | 上海君实生物医药科技股份有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-113549560-B | Construction method of engineering yeast for glycoprotein preparation and strain thereof | 中国人民解放军军事科学院军事医学研究院 | 2024-02-13 | — | — | CN | disclosed |
| CN-113797326-B | Vaccine for preventing diseases caused by coronaviruses | 上海君实生物医药科技股份有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-116622534-A | Engineering strain for high yield of 2' -fucosyllactose, construction method and application thereof | 山东大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-112175102-A | Preparation method and application of algal polysaccharide disease-resistant inducer | 华南农业大学 | 2021-01-05 | — | — | CN | disclosed |
| US-6566339-B1 | Administering analogue of mannose-6-phosphate for healing of wounds or fibrotic disorders | RENOVO LIMITED (GB) | 2003-05-20 | — | — | US | disclosed |
| EP-0841931-B1 | PHARMACEUTICAL COMPOSITION | RENOVO LTD (GB) | 2003-03-26 | — | — | EP | disclosed |
| EP-1291018-A1 | Pharmaceutical composition | Renovo Limited (GB) | 2003-03-12 | — | — | EP | disclosed |
| US-6140307-A | Pharmaceutical composition | THE VICTORIA UNIVERSITY OF MANCHESTER (GB) | 2000-10-31 | — | — | US | disclosed |
| EP-0841931-A1 | PHARMACEUTICAL COMPOSITION | THE VICTORIA UNIVERSITY OF MANCHESTER (GB) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997005883-A1 | PHARMACEUTICAL COMPOSITION | THE VICTORIA UNIVERSITY OF MANCHESTER (GB) | 1997-02-20 | — | — | WO | disclosed |
| CN-85101019-A | Assaying immunoliposome is analysed-method and product | — | 1987-01-10 | — | — | CN | disclosed |